Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
22 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting-302463001.html
20 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-demonstrates-commitment-to-oncology-innovation-at-asco-2025-302459508.html
19 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/eisai-biogen-leqembi-first-fda-approved-alzheimers-blood-test-takes-time-benefit-launch
19 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/eisai-mounts-targeted-tv-ad-push-raise-awareness-leqembi
15 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-projects-leqembi-revenue-to-total-jpy-76-5-billion-for-fiscal-year-2025-april-2025--march-2026-302456441.html
16 Apr 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorizes-eisai-biogens-drug-treatment-early-alzheimers-disease-2025-04-15/
Inspections and registrations
ABOUT THIS PAGE
Eisai is a supplier offers 19 products (APIs, Excipients or Intermediates).
Find a price of Azilsartan bulk with JDMF offered by Eisai
Find a price of Donepezil bulk with JDMF offered by Eisai
Find a price of Epalrestat bulk with JDMF offered by Eisai
Find a price of Eribulin bulk with JDMF offered by Eisai
Find a price of Fosravuconazole bulk with JDMF offered by Eisai
Find a price of Pranlukast Hydrate bulk with JDMF offered by Eisai
Find a price of Rabeprazole Sodium bulk with JDMF offered by Eisai
Find a price of Ramelteon bulk with JDMF offered by Eisai
Find a price of Teprenone bulk with JDMF offered by Eisai
Find a price of Vitamin E Acetate bulk with JDMF offered by Eisai
Find a price of Bentiromide bulk offered by Eisai
Find a price of Eperisone bulk offered by Eisai
Find a price of Menfegol bulk offered by Eisai
Find a price of Donepezil bulk offered by Eisai
Find a price of Eribulin bulk offered by Eisai
Find a price of Lenvatinib Mesylate bulk offered by Eisai
Find a price of Perampanel bulk offered by Eisai
Find a price of Rabeprazole Sodium bulk offered by Eisai
Find a price of Teprenone bulk offered by Eisai